DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Meningococcal Disease and Vaccines
April 14, 2022

The Florida Department of Health (FDOH) is responding to an outbreak of meningococcal disease in some areas of Florida. Continue reading


Second Quarter Performance Report
April 12, 2022

Released for the
2021 – 2022 Fiscal Year Continue reading




Supporting Documents

Medical Degree Verification
NICA FORM
Postgraduate Training Verification
License Verification

Supporting Documents - Visiting Physician

NICA FORM